Mohamed R Elnagar

17PUBLICATIONS
80CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsPredictive and prognostic markersBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 25, 2026
Discovery of tricyclic benzo[4,5]imidazo[2,1-b]thiazole-3-hydroxyindolin-2-one hybrids as selective MAO-B and cholinesterase inhibitors.

|Aug 18, 2026
Quinazolinone-triazole hybrids as multi-target-directed ligands for Alzheimer's disease: discovery of potent and selective MAO-B inhibitors with cholinesterase modulating activity.

|Aug 10, 2026
Targeting CDK-2 With Novel Indole-Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies.

|Jul 30, 2026
Design, synthesis, molecular docking and molecular dynamics simulations of pyrazolo[3,4-d]pyrimidine scaffolds as selective COX-2 and CDK2 kinase inhibitors with dual anti-inflammatory and anti-proliferative activities.

|Jul 28, 2026
Synthesis and Anticancer Activity of New Quinazolin-4(3H)-one Derivatives: Identification of a Tumor-Selective Anticancer Agent with Potential Inhibition of TGF-βRI (ALK5).

|Jul 01, 2026
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.

Pageof 3

Frequent Collaborators

6 joint publications

Haytham O Tawfik

6 joint publications

Wagdy M Eldehna

3 joint publications

Mohamed M Tawfik

2 joint publications

Mohamed R Abdelaal